| Product Code: ETC6739152 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cell & Gene Therapy Bioanalytical Testing Services Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, 2021 & 2031F |
3.3 China Cell & Gene Therapy Bioanalytical Testing Services Market - Industry Life Cycle |
3.4 China Cell & Gene Therapy Bioanalytical Testing Services Market - Porter's Five Forces |
3.5 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume Share, By Development, 2021 & 2031F |
3.8 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy research and development in China |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Favorable government regulations and policies supporting cell and gene therapy advancements |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy bioanalytical testing services |
4.3.2 Limited skilled workforce and expertise in specialized bioanalytical testing techniques in China |
5 China Cell & Gene Therapy Bioanalytical Testing Services Market Trends |
6 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Types |
6.1 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Bioavailability & Bioequivalence Studies, 2021- 2031F |
6.1.4 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Pharmacokinetics, 2021- 2031F |
6.1.5 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Pharmacodynamics, 2021- 2031F |
6.1.6 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Other Test Type, 2021- 2031F |
6.2 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2.3 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F |
6.2.4 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Development |
6.3.1 Overview and Analysis |
6.3.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Non-Clinical, 2021- 2031F |
6.3.3 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Clinical, 2021- 2031F |
6.4 China Cell & Gene Therapy Bioanalytical Testing Services Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.4 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Neurological disorders, 2021- 2031F |
6.4.5 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.4.6 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 China Cell & Gene Therapy Bioanalytical Testing Services Market Import-Export Trade Statistics |
7.1 China Cell & Gene Therapy Bioanalytical Testing Services Market Export to Major Countries |
7.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Imports from Major Countries |
8 China Cell & Gene Therapy Bioanalytical Testing Services Market Key Performance Indicators |
8.1 Adoption rate of cell and gene therapy bioanalytical testing services by pharmaceutical and biotech companies in China |
8.2 Number of clinical trials incorporating cell and gene therapy bioanalytical testing services in China |
8.3 Investment in research and development for innovative bioanalytical testing technologies in the field of cell and gene therapy |
9 China Cell & Gene Therapy Bioanalytical Testing Services Market - Opportunity Assessment |
9.1 China Cell & Gene Therapy Bioanalytical Testing Services Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Cell & Gene Therapy Bioanalytical Testing Services Market Opportunity Assessment, By Development, 2021 & 2031F |
9.4 China Cell & Gene Therapy Bioanalytical Testing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Cell & Gene Therapy Bioanalytical Testing Services Market - Competitive Landscape |
10.1 China Cell & Gene Therapy Bioanalytical Testing Services Market Revenue Share, By Companies, 2024 |
10.2 China Cell & Gene Therapy Bioanalytical Testing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here